Teodor Gottfried

411 total citations
13 papers, 312 citations indexed

About

Teodor Gottfried is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Teodor Gottfried has authored 13 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in Teodor Gottfried's work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (4 papers). Teodor Gottfried is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (4 papers). Teodor Gottfried collaborates with scholars based in Israel, United States and Italy. Teodor Gottfried's co-authors include Jair Bar, Amir Onn, Damien Urban, Sameh Daher, Elizabeth Dudnik, Iris Kamer, Iris Barshack, Raya Leibowitz‐Amit, Raanan Berger and Gal Markel and has published in prestigious journals such as International Journal of Cancer, European Journal of Cancer and Cancers.

In The Last Decade

Teodor Gottfried

13 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teodor Gottfried Israel 10 226 127 49 37 36 13 312
Daniela Cugino Italy 7 78 0.3× 26 0.2× 39 0.8× 24 0.6× 55 1.5× 8 272
Anna M. Wojtukiewicz Poland 6 143 0.6× 48 0.4× 12 0.2× 78 2.1× 70 1.9× 9 285
Veronika Sárosi Hungary 11 93 0.4× 180 1.4× 21 0.4× 28 0.8× 105 2.9× 30 311
Hiroyuki Ito Japan 13 116 0.5× 165 1.3× 25 0.5× 8 0.2× 72 2.0× 53 470
Hanxiang Liu China 10 212 0.9× 82 0.6× 31 0.6× 14 0.4× 40 1.1× 25 325
Μaria Anastasiou Greece 11 146 0.6× 93 0.7× 13 0.3× 48 1.3× 75 2.1× 40 306

Countries citing papers authored by Teodor Gottfried

Since Specialization
Citations

This map shows the geographic impact of Teodor Gottfried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teodor Gottfried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teodor Gottfried more than expected).

Fields of papers citing papers by Teodor Gottfried

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teodor Gottfried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teodor Gottfried. The network helps show where Teodor Gottfried may publish in the future.

Co-authorship network of co-authors of Teodor Gottfried

This figure shows the co-authorship network connecting the top 25 collaborators of Teodor Gottfried. A scholar is included among the top collaborators of Teodor Gottfried based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teodor Gottfried. Teodor Gottfried is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Daher, Sameh, Alona Zer, Roi Tschernichovsky, et al.. (2023). Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer. Lung Cancer. 178. 229–236. 14 indexed citations
2.
3.
Daher, Sameh, Yaacov Richard Lawrence, Elizabeth Dudnik, et al.. (2021). Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers. Frontiers in Oncology. 11. 625668–625668. 9 indexed citations
4.
Dudnik, Elizabeth, Jair Bar, Assaf Moore, et al.. (2021). BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors. Frontiers in Oncology. 11. 603223–603223. 14 indexed citations
5.
Kamer, Iris, Elizabeta Bab-Dinitz, Efrat Ofek, et al.. (2021). Immunotherapy response modeling by ex-vivo organ culture for lung cancer. Cancer Immunology Immunotherapy. 70(8). 2223–2234. 12 indexed citations
6.
Dudnik, Elizabeth, Mor Moskovitz, Chul Kim, et al.. (2021). Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung. Journal for ImmunoTherapy of Cancer. 9(2). e001999–e001999. 31 indexed citations
7.
Onn, Amir, Teodor Gottfried, Amos Stemmer, et al.. (2021). Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer. Cancers. 13(11). 2800–2800. 5 indexed citations
8.
Kamer, Iris, Yael Steuerman, Gili Perry, et al.. (2020). Predicting brain metastasis in early stage non-small cell lung cancer patients by gene expression profiling. Translational Lung Cancer Research. 9(3). 682–692. 22 indexed citations
9.
Dudnik, Elizabeth, Mor Moskovitz, Abed Agbarya, et al.. (2020). Alternative nivolumab duration and scheduling in advanced nonsmall cell lung cancer: A real‐world evidence. International Journal of Cancer. 148(5). 1183–1191. 1 indexed citations
10.
Gottfried, Teodor, Iris Kamer, Damien Urban, et al.. (2020). <p>Self-reported sleep quality as prognostic for survival in lung cancer patients</p>. Cancer Management and Research. Volume 12. 313–321. 23 indexed citations
11.
Magri, Valentina, Teodor Gottfried, Mattia Di Segni, et al.. (2019). <p>Correlation of body composition by computerized tomography and metabolic parameters with survival of nivolumab-treated lung cancer patients</p>. Cancer Management and Research. Volume 11. 8201–8207. 39 indexed citations
12.
Bar, Jair, Efrat Ofek, Iris Barshack, et al.. (2019). Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer. Lung Cancer. 138. 109–115. 44 indexed citations
13.
Bar, Jair, Gal Markel, Teodor Gottfried, et al.. (2019). Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study. European Journal of Cancer. 120. 122–131. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Cugino Breakdown of academic impact, for papers by Anna M. Wojtukiewicz Breakdown of academic impact, for papers by Veronika Sárosi Breakdown of academic impact, for papers by Hiroyuki Ito Breakdown of academic impact, for papers by Hanxiang Liu Breakdown of academic impact, for papers by Μaria Anastasiou
Rankless by CCL
2026